Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
Monster Beverage
MNST
|
$396M |
| 5 |
argenx
ARGX
|
$306M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $133K | ﹤0.01% |
+12,376
| New | +$133K |
|
2577
Hagerty
HGTY
$1.14B
| $132K | ﹤0.01% |
+15,071
| New | +$132K |
|
2578
Dyne Therapeutics
DYN
$1.92B
| $130K | ﹤0.01% |
+11,339
| New | +$130K |
|
|
BLUE
2579
DELISTED
bluebird bio
BLUE
| $130K | ﹤0.01% |
40,638
+18,690
| +85% | +$59.9K |
|
2580
SmartRent
SMRT
$273M
| $129K | ﹤0.01% |
50,516
+31,066
| +160% | +$79.1K |
|
2581
Douglas Elliman
DOUG
$241M
| $129K | ﹤0.01% |
41,330
+16,816
| +69% | +$52.3K |
|
2582
Cricut
CRCT
$1.21B
| $128K | ﹤0.01% |
+12,548
| New | +$128K |
|
|
HRT
2583
DELISTED
HireRight Holdings Corporation
HRT
| $127K | ﹤0.01% |
+11,972
| New | +$127K |
|
2584
Senseonics Holdings
SENS
$369M
| $126K | ﹤0.01% |
180,093
+105,792
| +142% | +$74.3K |
|
2585
LivePerson
LPSN
$86M
| $126K | ﹤0.01% |
28,624
-2,628,799
| -99% | -$11.6M |
|
|
AMRS
2586
DELISTED
Amyris Inc.
AMRS
| $126K | ﹤0.01% |
93,106
+61,271
| +192% | +$83K |
|
2587
Mersana Therapeutics
MRSN
$36.5M
| $126K | ﹤0.01% |
30,656
+19,315
| +170% | +$79.5K |
|
|
AMPS
2588
DELISTED
Altus Power, Inc.
AMPS
| $126K | ﹤0.01% |
22,904
+12,198
| +114% | +$67K |
|
|
TPC
2589
Tutor Perini Corporation
TPC
$3.11B
| $124K | ﹤0.01% |
+20,157
| New | +$124K |
|
2590
Ribbon Communications
RBBN
$722M
| $124K | ﹤0.01% |
36,181
+17,586
| +95% | +$60.1K |
|
2591
Erasca
ERAS
$454M
| $122K | ﹤0.01% |
+40,666
| New | +$122K |
|
|
PTRA
2592
DELISTED
Proterra Inc. Common Stock
PTRA
| $121K | ﹤0.01% |
80,029
+43,034
| +116% | +$65.2K |
|
2593
Atea Pharmaceuticals
AVIR
$267M
| $120K | ﹤0.01% |
35,909
+17,769
| +98% | +$59.3K |
|
|
NVTA
2594
DELISTED
Invitae Corporation
NVTA
| $119K | ﹤0.01% |
88,694
+54,375
| +158% | +$73.1K |
|
2595
Pulmonx
LUNG
$70.5M
| $119K | ﹤0.01% |
+10,672
| New | +$119K |
|
2596
1-800-Flowers.com
FLWS
$356M
| $117K | ﹤0.01% |
+10,205
| New | +$117K |
|
2597
NextDecade
NEXT
$2.8B
| $117K | ﹤0.01% |
23,543
+11,657
| +98% | +$58K |
|
2598
Funko
FNKO
$189M
| $117K | ﹤0.01% |
+12,431
| New | +$117K |
|
|
GPMT
2599
Granite Point Mortgage Trust
GPMT
$137M
| $116K | ﹤0.01% |
23,420
+12,219
| +109% | +$60.4K |
|
2600
Robinhood
HOOD
$89.6B
| $115K | ﹤0.01% |
11,896
+225
| +2% | +$2.18K |
|